WHO ICTRP trial

Quantitative EEG as biomarker for the prediction of seizures, depression and…

DRKS00017079 · German Clinical Trials Register · Recruiting

Key facts

Trial ID DRKS00017079
Public title Quantitative EEG as biomarker for the prediction of seizures, depression and cognitive decline after stroke - A substudy to the Berling Longterm Observation of Vascular Events - BeLOVE - Study
Scientific title Quantitative EEG as biomarker for the prediction of seizures, depression and cognitive decline after stroke - A substudy to the Berling Longterm Observation of Vascular Events - BeLOVE - Study
Primary sponsor Charité Campus Benjamin Franklin
Registry German Clinical Trials Register
Recruitment status Recruiting
Study type observational
Countries Germany
Conditions I63.9 G40.9;Cerebral infarction, unspecified;Epilepsy, unspecified;I63.9;G40.9
Interventions Group 1: Patients receive an EEG measurement with dry electrode EEG caps within seven days of a cerebrovascular event. In study visits after 90 days and two years and in anual telephone interviews, patients are screened for the presence of…
Registration date May 15, 2019
Target size 625
Registry page drks.de

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations